Abivax

Biotech IPOs: Abivax and Lexeo debut on Nasdaq, Apnimed delays listing

Biotech IPOs: Abivax and Lexeo debut on Nasdaq, Apnimed delays listing

Anika Sharma

AbiVax and Lexeo Therapeutics have recently made their debut in the world of initial public offerings (IPOs), marking the commencement ...